Clinical characteristics of patients with autosomal dominant polycystic kidney disease and risk factors for kidney function decline: a single-center study

Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) leads to end-stage renal disease (ESRD) in approximately half of all patients with ADPKD by their sixth decade of life. Factors that cause kidney function decline in these patients are unclear. Methods This retrospective study...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Masato Minami, Shiroh Tanoue, Takumi Ejima, Tsubasa Uruta, Satomi Ichida, Hidehito Nakamura, Masayuki Otsuka, Takahiro Arima, Rei Obo, Yawara Yamashita, Haruhito Yoshimine, Masaharu Abe, Yozo Yoshimine, Masahide Furusho, Eiji Saeki, Shuji Kanmura, Akio Ido
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2025-05-01
Rangatū:	Renal Replacement Therapy
Ngā marau:	ADPKD eGFR htTKV cyst infection proteinuria
Urunga tuihono:	https://doi.org/10.1186/s41100-025-00627-6
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!